General anti-infectives for systemic use and vaccines | Tenderlake

General anti-infectives for systemic use and vaccines

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
04 March 2022
Closing Date:
11 April 2022
Location(s):
BE213 Arr. Turnhout (BE Belgium/BELGIQUE-BELGIË)
Description:
FRAMEWORK AGREEMENT FOR THE PURCHASE OF ANTI-INFECTIOUS AGENTS

For this contract, AZ Herentals acts as a purchasing centre within the meaning of Article 47 §2 and Article 129 of the Law of 17 June 2016, which means that AZ Herentals will act in the capacity of contracting authorities on behalf of the various contracting authorities for this contract. The purchasing centre will apply the public procurement procedure according to the instructions and in the name and on behalf of the contracting authorities concerned.

At the end of the procedure, the central purchasing body will award the public contract if consensus has been reached by the contracting authorities. After the award has ended, the contracting authorities themselves must conclude an agreement with the contracting party to whom the public contract was awarded.

The purchasing centre shall be entrusted with the award and conclusion of the current contract in order to meet its own needs as well as those of other contracting authorities. (see assignment documents)

Aciclovir IV

See II.2.1

AMOXICILLIN + AMOXICLAV IN SYRUP

See II.2.1

ANIDULAFUNGIN 100 mg

See II.2.1

AZITHROMYCIN ON TABL+ SYRUP

See II.2.1

BENZYLPENICILLIN

See II.2.1

Caspofungin

See II.2.1

Cefazolin

See II.2.1

CEFEPIM IV

See II.2.1

CEFOTAXIM

See II.2.1

Ceftazidime IV

See II.2.1

Ceftriaxone IV

See II.2.1

Aciclovir PO

See II.2.1

CEFUROXIME IV

See II.2.1

CEFUROXIME ON

See II.2.1

Ciprofloxacin IV

See II.2.1

Ciprofloxacin PO

See II.2.1

CLARITHROMYCIN IN SYRUP

See II.2.1

CLARITHROMYCIN PO CAPS

See II.2.1

CLARITHROMYCIN PO - extended release

See II.2.1

Clindamycin IV

See II.2.1

Clindamycin PO

See II.2.1

DOXYCYCLINE

See II.2.1

AMPHOTERICIN B

See II.2.1

FLUCLOXACILLIN IV

See II.2.1

FLUCLOXACILLINE PO 500 mg

See II.2.1

Fluconazole IV

See II.2.1

Fluconazole PO

See II.2.1

ITRACONAZOLE PO 100 mg

See II.2.1

LEVOFLOXACIN IV 500 mg/ 100 ml

See II.2.1

Levofloxacin PO

See II.2.1

LINEZOLID IV 600 mg/ 300 ml

See II.2.1

Linezolid PO 600 mg

See II.2.1

Meropenem IV

See II.2.1

AMIKACIN IV

See II.2.1

METRONIDAZOLE IV

See II.2.1

MINOCYCLINE PO

See II.2.1

MOXIFLOXACIN IV 400 mg/250 ml

See II.2.1

MOXIFLOXACIN PO 400 mg

See II.2.1

NYSTATIN PO 100000IU/1 ml

See II.2.1

Piperacillin + Tazobactam

See II.2.1

POSACONAZOLE ON TABL 100 mg

See II.2.1

SULFAMETHOXAZOLE + TRIMETHOPRIM PO 800 mg + 160 mg

See II.2.1

TERBINAFINE PO 250 mg

See II.2.1

VALACICLOVIR PO 500 mg

See II.2.1

AMOXICILLIN

See II.2.1

VALGANCICLOVIR PO 450 mg

See II.2.1

Vancomycin IV

See II.2.1

VORICONAZOLE IV 200 mg

See II.2.1

VORICONAZOLE TABLE-TOP

See II.2.1

AMOXICILLIN PO

See II.2.1

Amoxicillin + Clavulanic Acid IV

See II.2.1

AMOXICILLIN + AMOXICLAV PO 500 mg + 125 mg

See II.2.1

AMOXICILLIN + AMOXICLAV PO 875 mg + 125 mg -extended release

See II.2.1

Download full details as .pdf
The Buyer:
AZ St.-Elisabeth Herentals vzw
CPV Code(s):
33651000 - General anti-infectives for systemic use and vaccines